Methodology
Understanding how PrismDX detects and surfaces AI diagnostic bias
PrismDX is a point-of-care demographic bias overlay designed to fill a critical gap in current MLOps tools. While most AI monitoring focuses on aggregate model performance, PrismDX surfaces potential bias flags directly to clinicians at the moment of diagnosis—when it matters most.
Research has consistently shown that AI diagnostic models can exhibit reduced accuracy for underrepresented demographic groups, particularly in dermatology and radiology. PrismDX provides real-time visibility into these disparities, empowering clinicians to make informed decisions about when additional verification is warranted.
Core Capabilities
Point-of-Care Bias Overlay
PrismDX acts as a transparent layer over existing AI diagnostic tools, flagging potential demographic biases in real-time without disrupting clinical workflow.
Research-Backed Baselines
Our bias detection algorithms are calibrated against peer-reviewed research from Nature Medicine, JAMA, and other leading medical journals documenting AI performance disparities.
Proactive Alerting
When confidence levels fall below demographic-specific baselines, clinicians receive immediate alerts with actionable recommendations for additional verification.
Audit Trail
Every scan generates a complete audit trail documenting the bias evaluation, enabling compliance with emerging AI healthcare regulations.
Image Analysis
The medical image is processed through the primary diagnostic AI model, generating a diagnosis and raw confidence score.
Demographic Contextualization
Patient demographic data (Fitzpatrick scale, age, gender) is cross-referenced against our baseline database derived from published research.
Bias Evaluation
If the confidence score deviates significantly from expected baselines for the patient's demographic group, a bias flag is triggered.
Clinical Decision Support
The clinician receives the diagnosis alongside bias evaluation data, enabling informed decisions about additional verification or specialist consultation.
| Fitzpatrick Type | Expected Baseline | Observed Avg. | Status |
|---|---|---|---|
| Type I | 95% | 94% | Normal |
| Type II | 94% | 92% | Normal |
| Type III | 92% | 89% | Normal |
| Type IV | 90% | 85% | Monitor |
| Type V | 90% | 78% | Bias Alert |
| Type VI | 90% | 72% | Bias Alert |
Data derived from: Adamson AS, Smith A. Machine Learning and Health Care Disparities in Dermatology. JAMA Dermatology. 2018; Daneshjou R et al. Disparities in dermatology AI performance. Nature Medicine. 2024.
Continuous Updates
Our baseline database is continuously updated as new research is published. PrismDX monitors leading journals for relevant studies on AI diagnostic disparities.